Page 144 - CW E-Magazine (29-7-2025)

Top Stories Pharmaceuticals

RESEARCH IN RENEWABLES HUGE DATA REQUIREMENT
IIT-B develops low-cost solar cell, to launch pilot facility Drug fi rms seek time to transition to regulatory

The Indian Institute of Technology to set up a pilot manufacturing facility at ing for effi cient and scalable solar requirement for RoW exports
(IIT) Bombay has developed a solar IIT-B, to help turn Indian research into energy solutions, this breakthrough gives
cell that could play a vital role in India’s commercially viable technology. India a leadership edge,” Joshi said. Drug fi rms are seeking at least six (COPP) applications through the is already in place for regulated mar-
clean energy future. The innovation “This is not just a lab-scale innova- more months to comply with a regula- ONDLS portal was July 15, which kets like the US and the Europe. But
comes from the Advanced Renewable During his visit, the Minister toured tion, it is a blueprint for clean, scalable, tory requirement of uploading a com- was extended by a month. for exports to RoW, the certifi cate is
Tandem-Photovoltaics India (ART-PV the Perovskite Tandem Solar Cell Lab, and self-reliant energy production,” he pliances-linked certifi cate onto a cen- given by State authorities. This has
India), a start-up incubated at IIT Bombay the Silicon Fab Lab and the Medium added. tral website, which will allow them to The industry is not against the cen- its benefi ts in terms of physically ad-
(IIT-B). Voltage Lab at NCPRE. Following his export to the Rest-of-the-World (RoW) tralisation, Mr. Joshi said, but transi- dressing queries raised by the regula-
tour, he described the low-cost solar Underlining the importance of regions, Mr. Namit Joshi, Chairman tioning to the system would require tor, said Mr. Joshi, adding that it would
Union Minister for New and Renew- cell innovation as a “game-changer” moving beyond the lab, Joshi encouraged of the Pharmaceuticals Export Pro- at least six months. “It will take some not be possible on a centralised online
able Energy (MNRE), Pralhad Joshi, for India’s energy ambitions, one that the IIT Bombay and ART-PV India teams motion Council of India (Pharm- time because loading a humongous system.
visited the National Centre for Photovol- strengthens the country’s leadership in to focus on commercial deployment. excil), was quoted as saying in news amount of data into the system is not
taic Research and Education (NCPRE) clean energy technology. “We must show that these perovskite reports. feasible immediately,” he said. The Turnaround time
at IIT-Bombay recently. MNRE is also tandem solar cells are not only scalable RoW regions account for 45 percent The online service provider and regu-
backing ART-PV India with Rs. 83-crore “At a time when the world is search- but also profi table,” he noted. He said that a “humungous” amount of India’s $ 30-bn-odd pharmaceutical latory authority also need to be time-
Dow India recognised as one of India’s best of data would have to be uploaded on exports, he said. bound in terms of seeking and clearing
queries because any delay would allow
the ONDLS (Online National Drugs
companies to work for licensing system) portal, and that The COPP certifi cate facilitates competitors like China to further rush
would not just take time for companies exports by refl ecting the Good Manu-
in, following which it would be diffi -
(including MSMEs), but the online facturing Practises-linked compliances cult for Indian companies, Mr. Joshi
Dow Chemical International Pvt. services need to be ready to handle the like quality, reliability and sustaina- explained.
Ltd. (Dow India) has been recognised as load as well. bility, explained Mr. Joshi. This is an
one of India’s ‘Best Companies To Work important responsibility of the country Once the data is uploaded, queries
For’, and has earned the distinction of The deadline set by Central and regulators approving the pharma should be raised in a couple of days,
‘Best Workplaces in Chemicals in India Drugs Standard Control Organisation exports, he added. and once the justifi cation is given, the
2025’. (CDSCO) for online submission of the COPP should be issued in 24 or 48
Certifi cate of Pharmaceutical Product The centralised certifi cation system hours, he said.
Presented by Great Place To Work,
these accolades honour organisations Emcure and Sanofi ink distribution partnership
that have created remarkable employee
experiences, fostering inclusive culture, for oral anti-diabetic drugs
and set high standards in workplace
practices. “This recognition highlights Pune-based Emcure Pharma and include brands like Amaryl and Cetapin.
Dow India’s commitment to building a work environment – reinforcing its thinking leader in the chemical industry,” Sanofi India Ltd. (SIL) have entered into While SIL will continue to own and
resilient, growth-driven, and inclusive position as a trusted and forward- the company said. an exclusive distribution and promotion manufacture these brands across Sanofi ’s

Rajan Gajaria is new Vice Chairman of UPL’s Advanta agreement for SIL’s oral anti-diabetic plants in India and internationally,
Emcure will leverage its strengths to
(OAD) products in India. Emcure will
Seeds exclusively distribute and promote the expand reach of these therapeutic solu-
tions for patients.
company’s OAD range of products that
Advanta Seeds, a global seed com- years of experience in focus will be on “pro-
pany and part of the UPL Group, has the agriculture industry. viding strategic leadership, Lupin gets GMP certifi cation from TGA Australia
announced the appointment of Rajan He joins Advanta fol- driving shareholder value for Dabhasa API facility
Gajaria as Vice Chairman. lowing a distinguished through disciplined invest-
career at Corteva Agri- ment strategies and leading Mumbai-based Lupin has an- in Dabhasa, Gujarat, has received the tralia’s medicines and medical devices
Gajaria has been serving as a Board science. inorganic growth through nounced that the API manufacturing Good Manufacturing Practice (GMP) regulator. LMS offers pharmaceutical
member of UPL SAS and Advanta for targeted mergers and ac- facility of its wholly-owned subsidiary, certifi cation from the Therapeutic CDMO services and is engaged in the
the past two years and brings over 30 Advanta said Gajaria’s quisitions”. Lupin Manufacturing Solutions (LMS), Goods Administration (TGA), Aus- manufacturing and supply of APIs.

144 Chemical Weekly July 29, 2025 Chemical Weekly July 29, 2025 145

Contents Index to Advertisers Index to Products Advertised